SlideShare a Scribd company logo
1 of 34
Download to read offline
The Coulter Principle for Cellular and 
      Biological Applications




             Multisizer™ 4
The Coulter Principle

 • The Coulter Principle, which uses electrical 
   impedance to measure particulate volume was 
   developed over 60 years ago for counting and 
   sizing red blood cells.  
 • It is the subject of numerous ASTM and ISO 
   standards for sizing and counting.  
 • It is independent of particle refractive index, 
   chemistry, etc.  It will detect any particle that 
   displaces liquid.
The Coulter Principle in Practice




  Particles, liquid and electric current are pumped through an 
  orifice of an exact diameter 
  The particles cause changes in the electric current & these 
  changes are monitored to count and size particles
Current Users of the Multisizer

     •   Georgia Tech   •   UC Berkeley   •   UCLA
     •   MIT            •   Leiden U.     •   Lehigh U.
     •   Harvard        •   McGill U.     •   RIT
     •   U. Texas       •   U. Chicago    •   Johns Hopkins
     •   UC London      •   NYU           •   Columbia
Studying Cell Death
(Apopotosis)
 • Apopotosis involves the swelling and breaking apart of cellular 
   structure
 • Carefully designed studies can use the Coulter Principle to 
   understand the role of various chemicals, proteins, etc. in the 
   process




        http://www.microbiologybytes.com/virology/kalmakoff/baculo/pics/Apoptosis.gif
Cell Shrinkage is a prerequisite 
for Apopotosis




               Maeno, et al. PNAS 2000, 97, 17, 9487
Determining Fertility 
based on Sperm Volume




             Hossain, et al, Human Reproduction, 13. 6. 1578-1583. 1998

    • Depending on the time of year, farm animals display 
      high or low fertility (counts)
    • Volume changes can be indicative of disorders (size)
Effect of Quinine on Sperm




              Yeung, et al, J. of Andrology, 23. 4. 522-528 2002
Characterization of Cell Culture

    Industrial scale cell cultures require constant   
    monitoring and analysis
    Coulter Counter provides answers to many 
    common questions
          How big are the host cells?
          How uniform are  the host cells?
          Have any of the host cells broken apart?
          What is the relative percentage of debris to 
          desired cell type?
Characterization of host rDNA 
Cell Culture
Environmental Conditions 
Effect Cell Stability and Viability  
Filtration Efficiency




  • After growing up cell culture, filtration is used to remove debris
  • Key parameters are efficiency and fouling‐ batch differences in 
    media culture can cause filter fouling
  • The Coulter Principle can be used to help select filters that 
    perform the best
Data from Major Pharma Company




  Company was interested in removing the cellular debris/fragments prior to 
 pumping the supernatant into downstream processing steps.  First two curves 
  are as harvested (showing debris/fragment concentrations).  The remaining 
   curves are samples set aside in beakers etc that were then sampled. Two 
               different clarification filtering systems were used.
Cell Banking:  Real Time 
Measurement of Changes in Cell Size 
  • To permanently preserve cell lines, cryoprotectants are 
    used prior to freezing
  • Cryoprotectants themselves cause cell damage
  • Studying the rate of this damage and changes in cell size as 
    a function of time allows users to make better decisions 
    about preservation methods




                  Mukherjee, et al, Cryobiology, 55(1):10-18. 2007
Multi‐Tube Overlap: 
Bacterial Aggregation in a Culture




  Bacterial aggregates can reduce the effectiveness of antimicrobial agents. A 
  combination of detergents and filters can be used to decrease the amount of 
  'clumps'.  The percentage of 'clumps' relative to single cells can be determined 
  by using two different apertures. The Multi‐Tube Overlap function merges the 
  results into a single continuous distribution.
Corollary I: Which Bead 
Formulations?

    • Micron Sized Beads are used in a variety of 
      cellular and biological applications
         Typically coated with recognition molecules
         Can be dye‐loaded, magnetic, or other…
         Optimization of formulation conditions is key

    • The Coulter Principle is the only technique that 
      can provide the resolution necessary for these 
      studies
Corollary I: Which Bead 
Formulations?


                                     Formulation A



           ~6

                                             Formulation B
                       ~12
                                 ~18      ~24



     The volume peaks increase by multiples of 6, indicating singlets,
     doublets, triplets, etc.
Corollary II: Microbubble 
Characterization
• Large beads (2‐20 micron)
     Hollow and filled with imaging agents
     Most typically applied in ultrasound
     Heavy focus for biomedical research

• The MultisizerTM allows researchers to 
  characterize these emerging imaging agents
Particulates and Aggregates in Protein 
             Formulations




    Beckman Coulter Particle Characterization
Protein Aggregates: Overview

    •   Problem statement
    •   The opportunity
    •   How the Coulter Principle competes
    •   Voice of the customer
    •   Frequently asked questions
    •   References
    •   The Coulter Principle
Problem Statement:

• Protein scientists have identified an overlooked region of
  product quality data.
     Currently, techniques such as AUC, CE, and chromatography provide
     information up to 100 nm particles in size.
     Other technologies, such as light blockage provide information above 10 micron
     in size.
• A “blind spot” exists with particles between 100 nm and 10
  micron.
     Particles in this range may cause immunogenicity.
     Active studies of this size range began in mid-2008.
     Regulators are demanding data in this range.


                                   Journal of Pharmaceutical Science-2009
Genzyme Case Study:
Importance of Particles in Biologics

     Genzyme says FDA will oversee its factory
                       By ANDREW POLLACK
              NEW YORK TIMES, Published: March 24, 2010

  November 2009
    FDA reports that Cerezyme, Fabrazyme and three other
    enzyme drugs that are put into vials at the factory were
    contaminated with PARTICLES of steel, rubber or fiber.
    Financial analyst predicts the overall cost to the Genzyme
    will be in the $200 million to $300 million range

                          Key Message
       FOREIGN OR PROTEINACEUOS PARTICLES
      HAVE THE POTENTIAL TO MAKE PEOPLE SICK
The Opportunity:

 Regulatory pressure is forcing manufacturers to 
 account for particulates of smaller and smaller 
 sizes.  
     Current lower limit =10 micron
     Likely future lower limit = 1 micron

 Currently used technologies do not perform well 
 below 10 micron
     The Multisizer™4 has been shown to be very 
     effective in this size range.
The Opportunity:

• FDA & EMEA require data for particulates less 
  than 10 micron, but do not specify the technique 
  that should be used.
    USP and EDQM pharmacopeias DO establish 
    acceptable techniques for FOREIGN particles greater 
    than 10 µm
    Two current, acceptable techniques for foreign 
    particulates greater than 10 µm
     ‐ Technique 1: Light Obscuration
     ‐ Technique 2: Microscopy


                   USP: United States Pharmacopeia
                   EMEA: European Medicines Agency
The Opportunity:

 • Competing techniques being evaluated for 
   particulates less than 10 micron:
     The Coulter Principle (BEC)
     Light Blockage (HIAC)
     Flow Imaging (MFI, Flowcam)
Opportunity Matrix:

     Particulate               Less than                  Greater than
    Characteristics            10 micron                   10 micron

       Foreign                                          Covered by current
                          Opportunity for MS4
      Particulates                                     USP & EMEA Methods


        Protein
                          Opportunity for MS4           Opportunity for MS4
      Aggregates




                     USP: United States Pharmacopeia
                     EMEA: European Medicines Agency
Coulter Principle: Advantage

           MultisizerTM 4 Data from Actual Protein Therapeutic
                 1.20E+05
                                                       Pre-filtration
                                  Approx. flow         Post-Filtration
 Number per mL




                                  imaging
                                  lower limit
                                  (~1.5 μm)
                 6.00E+04
                                                          Approx. light
                                                          blockage
                                                          lower limit
                                                          (~2 μm)
                 0.00E+00
                            0.4             1.9                           3.4
                                      Diameter (mm)
                                       Diameter (μm)


    Other techniques miss the majority
              of particulates
Technique Comparison:

                                Handles        Min
                Operating                             Min          Max
                              Transparent    Sample
                Principle      Particles?             Size     Concentration
                                             Volume

    Light                                              2.0        18,000
                Light Based   Questionable    2 mL
  Blockage                                            micron    particles/mL


    Flow                                               1.5        750,000
                Light Based   Questionable    2 mL
  Imaging                                             micron    particles/mL


   Coulter
                                                       0.4      >1,000,000
  Principle     Impedance      Excellent      4 mL
                                                      micron    particles/mL
 MultisizerTM
How can we estimate aggregate mass?




                     Mass = Density x Volume
Aspherical Objects: Preview
Voice of the Customer:

 “We WANT…”
   1. Accurate counts below 10 micron, and 
      ideally as low as 0.1 micron
   2. The ability to run samples neat
   3. Total sampling volumes between 2 and 5 mL
   4. Extremely linear and reproducible data
How We Meet Customer Needs:
Accurate counts below 10μm, ideally as low as 0.1μm 
     The MS4 is the only instrument that can count particulates 
     under 1 μm and down to 0.400 μm. 
The ability to run samples neat 
     The MS4 can count proteins in a wide variety of native buffers 
     without dilution 
Sampling volumes between 2 and 5 mL 
     Our new sample procedure and adaptor allow s volumes as 
     small as 4 mL 
Extremely linear and reproducible data 
     The MS4 is highly sensitive and reproducible 
     Typical CV's are below 2% 
     The Coulter Principle has been used as the #1 method for 
     counting red blood cells for over 50 years 
Frequently Asked Questions

“Do you have to dilute?”
    Not necessarily.  Depends on sample characteristics and 
    smallest size range needed.  
    Protein scientists often dilute for other analyses (size 
    exclusion chromatography, CE, AUC)
“Can you provide morphology information?”
    Ask why this is important.  Customers are most 
    concerned about counts and current flow image 
    techniques and rely upon image aspect ratios for 
    morphology
Frequently Asked Questions

 “Can you count down to 100 nm?”
     How low can you count now? The MultisizerTM is the 
     only instrument with accurate and reproducible data 
     below 1 micron.
 “What sample volumes are required?”
     The standard set up accommodates 10 mL.  However, 
     we have a special technique for proteins that can use 
     as little as 4 mL.
 “What is the Coulter Principle?”
     It uses electrical impedance to count and size 
     particles.  It has been around for more than 55 years 
     and widely used as a counting standard.

More Related Content

What's hot

Serum iron estimation & total iron
Serum iron estimation & total ironSerum iron estimation & total iron
Serum iron estimation & total ironSchool of science
 
Automated cell counters
Automated  cell countersAutomated  cell counters
Automated cell countersRicha Sharma
 
Estimation of serum albumin by Dr.Tehmas
Estimation of serum albumin by Dr.TehmasEstimation of serum albumin by Dr.Tehmas
Estimation of serum albumin by Dr.TehmasTehmas Ahmad
 
Chemiluminescence Immunoassay (CLIA) Technique
Chemiluminescence Immunoassay (CLIA) TechniqueChemiluminescence Immunoassay (CLIA) Technique
Chemiluminescence Immunoassay (CLIA) TechniqueTapeshwar Yadav
 
Haemocytometry.
Haemocytometry.Haemocytometry.
Haemocytometry.globalsoin
 
VANILLYLMANDELIC ACID ESTIMATION
VANILLYLMANDELIC ACID ESTIMATIONVANILLYLMANDELIC ACID ESTIMATION
VANILLYLMANDELIC ACID ESTIMATIONRaghwendra sah
 
serum protein estimation
serum protein estimationserum protein estimation
serum protein estimationtonnybite
 
Nephelometry, turbidometry & Reflectance photometry by Dr. Anurag Yadav
Nephelometry, turbidometry & Reflectance photometry by Dr. Anurag YadavNephelometry, turbidometry & Reflectance photometry by Dr. Anurag Yadav
Nephelometry, turbidometry & Reflectance photometry by Dr. Anurag YadavDr Anurag Yadav
 
Automation in hematology
Automation in hematologyAutomation in hematology
Automation in hematologyDr Siddartha
 
Cytochemical staining checked
Cytochemical staining checkedCytochemical staining checked
Cytochemical staining checkedBALRAM KRISHAN
 
PLATELET COUNT by Dr. Pandian M .pptx
PLATELET COUNT by Dr. Pandian M .pptxPLATELET COUNT by Dr. Pandian M .pptx
PLATELET COUNT by Dr. Pandian M .pptxPandian M
 

What's hot (20)

Serum iron estimation & total iron
Serum iron estimation & total ironSerum iron estimation & total iron
Serum iron estimation & total iron
 
Automated cell counters
Automated  cell countersAutomated  cell counters
Automated cell counters
 
Estimation of serum albumin by Dr.Tehmas
Estimation of serum albumin by Dr.TehmasEstimation of serum albumin by Dr.Tehmas
Estimation of serum albumin by Dr.Tehmas
 
Chemiluminescence Immunoassay (CLIA) Technique
Chemiluminescence Immunoassay (CLIA) TechniqueChemiluminescence Immunoassay (CLIA) Technique
Chemiluminescence Immunoassay (CLIA) Technique
 
Haemocytometry.
Haemocytometry.Haemocytometry.
Haemocytometry.
 
Automation
AutomationAutomation
Automation
 
VANILLYLMANDELIC ACID ESTIMATION
VANILLYLMANDELIC ACID ESTIMATIONVANILLYLMANDELIC ACID ESTIMATION
VANILLYLMANDELIC ACID ESTIMATION
 
serum protein estimation
serum protein estimationserum protein estimation
serum protein estimation
 
Hematology auto analyzer
Hematology auto analyzerHematology auto analyzer
Hematology auto analyzer
 
Chemiluminescence
ChemiluminescenceChemiluminescence
Chemiluminescence
 
Auto analyzer
Auto analyzerAuto analyzer
Auto analyzer
 
Nephelometry, turbidometry & Reflectance photometry by Dr. Anurag Yadav
Nephelometry, turbidometry & Reflectance photometry by Dr. Anurag YadavNephelometry, turbidometry & Reflectance photometry by Dr. Anurag Yadav
Nephelometry, turbidometry & Reflectance photometry by Dr. Anurag Yadav
 
Automation in hematology
Automation in hematologyAutomation in hematology
Automation in hematology
 
Pcv
PcvPcv
Pcv
 
Pcv
PcvPcv
Pcv
 
Dyes and stain
Dyes and stainDyes and stain
Dyes and stain
 
Rbc count
Rbc countRbc count
Rbc count
 
Cytochemical staining checked
Cytochemical staining checkedCytochemical staining checked
Cytochemical staining checked
 
PLATELET COUNT by Dr. Pandian M .pptx
PLATELET COUNT by Dr. Pandian M .pptxPLATELET COUNT by Dr. Pandian M .pptx
PLATELET COUNT by Dr. Pandian M .pptx
 
Estimation of uric acid
Estimation of uric acidEstimation of uric acid
Estimation of uric acid
 

Similar to The Coulter Principle for Cellular & Biological Applications

Bio-optical Sensing Dissertation
Bio-optical Sensing DissertationBio-optical Sensing Dissertation
Bio-optical Sensing DissertationRicky Hennessy
 
Clean And Stable Ds Aldrich Aaps Nbc May 2010 Low Rez
Clean And Stable Ds Aldrich Aaps Nbc May 2010 Low RezClean And Stable Ds Aldrich Aaps Nbc May 2010 Low Rez
Clean And Stable Ds Aldrich Aaps Nbc May 2010 Low RezD Scott Aldrich
 
Medimmune_022108
Medimmune_022108Medimmune_022108
Medimmune_022108WISBIOMED
 
Microscopy in food research
Microscopy in food researchMicroscopy in food research
Microscopy in food researchAmit Chauhan
 
Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...MilliporeSigma
 
Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...Merck Life Sciences
 
Cytation 3 single sheet english
Cytation 3 single sheet   englishCytation 3 single sheet   english
Cytation 3 single sheet englishMaziar Yari
 
Cytation 3 single sheet english
Cytation 3 single sheet   englishCytation 3 single sheet   english
Cytation 3 single sheet englishMaziar Yari
 
Non-Melanoma Skin cancer management diagnosis.pdf
Non-Melanoma Skin cancer management diagnosis.pdfNon-Melanoma Skin cancer management diagnosis.pdf
Non-Melanoma Skin cancer management diagnosis.pdfPavan Reddy
 
Role of Bio Mems in Novel Drug Delivery
Role of Bio Mems in Novel Drug DeliveryRole of Bio Mems in Novel Drug Delivery
Role of Bio Mems in Novel Drug DeliveryBrahmanandaSwain2
 
Employing ForteBio Octet platform for the development of a dual-binding poten...
Employing ForteBio Octet platform for the development of a dual-binding poten...Employing ForteBio Octet platform for the development of a dual-binding poten...
Employing ForteBio Octet platform for the development of a dual-binding poten...KBI Biopharma
 
Subvisible Particle Characterization: Why Simply Counting Shadows Leaves You ...
Subvisible Particle Characterization: Why Simply Counting Shadows Leaves You ...Subvisible Particle Characterization: Why Simply Counting Shadows Leaves You ...
Subvisible Particle Characterization: Why Simply Counting Shadows Leaves You ...KBI Biopharma
 
Methods of particle size measrement (032)
Methods of particle size measrement (032)Methods of particle size measrement (032)
Methods of particle size measrement (032)Hafiz Luqman Khalil
 
Characterization of nanoparticles & its regulatory aspects
Characterization of nanoparticles & its regulatory aspectsCharacterization of nanoparticles & its regulatory aspects
Characterization of nanoparticles & its regulatory aspectsvivek vyas
 
Instrumentation and application of LC-MS/MS in bioanalysis
Instrumentation and application of LC-MS/MS in bioanalysisInstrumentation and application of LC-MS/MS in bioanalysis
Instrumentation and application of LC-MS/MS in bioanalysisDr. Amit Patel
 
Pda Visual Inspection 2009 Aldrich
Pda Visual Inspection 2009 AldrichPda Visual Inspection 2009 Aldrich
Pda Visual Inspection 2009 AldrichD Scott Aldrich
 

Similar to The Coulter Principle for Cellular & Biological Applications (20)

Bio-optical Sensing Dissertation
Bio-optical Sensing DissertationBio-optical Sensing Dissertation
Bio-optical Sensing Dissertation
 
Clean And Stable Ds Aldrich Aaps Nbc May 2010 Low Rez
Clean And Stable Ds Aldrich Aaps Nbc May 2010 Low RezClean And Stable Ds Aldrich Aaps Nbc May 2010 Low Rez
Clean And Stable Ds Aldrich Aaps Nbc May 2010 Low Rez
 
Medimmune_022108
Medimmune_022108Medimmune_022108
Medimmune_022108
 
Microscopy in food research
Microscopy in food researchMicroscopy in food research
Microscopy in food research
 
Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...
 
Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...
 
PURE_Poster
PURE_PosterPURE_Poster
PURE_Poster
 
Cytation 3 single sheet english
Cytation 3 single sheet   englishCytation 3 single sheet   english
Cytation 3 single sheet english
 
Cytation 3 single sheet english
Cytation 3 single sheet   englishCytation 3 single sheet   english
Cytation 3 single sheet english
 
Non-Melanoma Skin cancer management diagnosis.pdf
Non-Melanoma Skin cancer management diagnosis.pdfNon-Melanoma Skin cancer management diagnosis.pdf
Non-Melanoma Skin cancer management diagnosis.pdf
 
Role of Bio Mems in Novel Drug Delivery
Role of Bio Mems in Novel Drug DeliveryRole of Bio Mems in Novel Drug Delivery
Role of Bio Mems in Novel Drug Delivery
 
Micromeritics
Micromeritics Micromeritics
Micromeritics
 
Vectus diode laser iml
Vectus diode laser imlVectus diode laser iml
Vectus diode laser iml
 
size reduction equipments
size reduction equipmentssize reduction equipments
size reduction equipments
 
Employing ForteBio Octet platform for the development of a dual-binding poten...
Employing ForteBio Octet platform for the development of a dual-binding poten...Employing ForteBio Octet platform for the development of a dual-binding poten...
Employing ForteBio Octet platform for the development of a dual-binding poten...
 
Subvisible Particle Characterization: Why Simply Counting Shadows Leaves You ...
Subvisible Particle Characterization: Why Simply Counting Shadows Leaves You ...Subvisible Particle Characterization: Why Simply Counting Shadows Leaves You ...
Subvisible Particle Characterization: Why Simply Counting Shadows Leaves You ...
 
Methods of particle size measrement (032)
Methods of particle size measrement (032)Methods of particle size measrement (032)
Methods of particle size measrement (032)
 
Characterization of nanoparticles & its regulatory aspects
Characterization of nanoparticles & its regulatory aspectsCharacterization of nanoparticles & its regulatory aspects
Characterization of nanoparticles & its regulatory aspects
 
Instrumentation and application of LC-MS/MS in bioanalysis
Instrumentation and application of LC-MS/MS in bioanalysisInstrumentation and application of LC-MS/MS in bioanalysis
Instrumentation and application of LC-MS/MS in bioanalysis
 
Pda Visual Inspection 2009 Aldrich
Pda Visual Inspection 2009 AldrichPda Visual Inspection 2009 Aldrich
Pda Visual Inspection 2009 Aldrich
 

Recently uploaded

Exploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusExploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusZilliz
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024The Digital Insurer
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...apidays
 
[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdfSandro Moreira
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...DianaGray10
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...apidays
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...apidays
 
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Angeliki Cooney
 
Six Myths about Ontologies: The Basics of Formal Ontology
Six Myths about Ontologies: The Basics of Formal OntologySix Myths about Ontologies: The Basics of Formal Ontology
Six Myths about Ontologies: The Basics of Formal Ontologyjohnbeverley2021
 
WSO2's API Vision: Unifying Control, Empowering Developers
WSO2's API Vision: Unifying Control, Empowering DevelopersWSO2's API Vision: Unifying Control, Empowering Developers
WSO2's API Vision: Unifying Control, Empowering DevelopersWSO2
 
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ..."I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...Zilliz
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FMESafe Software
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAndrey Devyatkin
 
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...Zilliz
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWERMadyBayot
 
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...apidays
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FMESafe Software
 
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Orbitshub
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerThousandEyes
 

Recently uploaded (20)

Exploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusExploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with Milvus
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
 
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
 
Six Myths about Ontologies: The Basics of Formal Ontology
Six Myths about Ontologies: The Basics of Formal OntologySix Myths about Ontologies: The Basics of Formal Ontology
Six Myths about Ontologies: The Basics of Formal Ontology
 
WSO2's API Vision: Unifying Control, Empowering Developers
WSO2's API Vision: Unifying Control, Empowering DevelopersWSO2's API Vision: Unifying Control, Empowering Developers
WSO2's API Vision: Unifying Control, Empowering Developers
 
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ..."I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of Terraform
 
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
 
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
 
Understanding the FAA Part 107 License ..
Understanding the FAA Part 107 License ..Understanding the FAA Part 107 License ..
Understanding the FAA Part 107 License ..
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 

The Coulter Principle for Cellular & Biological Applications

  • 1. The Coulter Principle for Cellular and  Biological Applications Multisizer™ 4
  • 2. The Coulter Principle • The Coulter Principle, which uses electrical  impedance to measure particulate volume was  developed over 60 years ago for counting and  sizing red blood cells.   • It is the subject of numerous ASTM and ISO  standards for sizing and counting.   • It is independent of particle refractive index,  chemistry, etc.  It will detect any particle that  displaces liquid.
  • 3. The Coulter Principle in Practice Particles, liquid and electric current are pumped through an  orifice of an exact diameter  The particles cause changes in the electric current & these  changes are monitored to count and size particles
  • 4. Current Users of the Multisizer • Georgia Tech • UC Berkeley • UCLA • MIT • Leiden U. • Lehigh U. • Harvard • McGill U. • RIT • U. Texas • U. Chicago • Johns Hopkins • UC London • NYU • Columbia
  • 5. Studying Cell Death (Apopotosis) • Apopotosis involves the swelling and breaking apart of cellular  structure • Carefully designed studies can use the Coulter Principle to  understand the role of various chemicals, proteins, etc. in the  process http://www.microbiologybytes.com/virology/kalmakoff/baculo/pics/Apoptosis.gif
  • 6. Cell Shrinkage is a prerequisite  for Apopotosis Maeno, et al. PNAS 2000, 97, 17, 9487
  • 7. Determining Fertility  based on Sperm Volume Hossain, et al, Human Reproduction, 13. 6. 1578-1583. 1998 • Depending on the time of year, farm animals display  high or low fertility (counts) • Volume changes can be indicative of disorders (size)
  • 8. Effect of Quinine on Sperm Yeung, et al, J. of Andrology, 23. 4. 522-528 2002
  • 9. Characterization of Cell Culture Industrial scale cell cultures require constant    monitoring and analysis Coulter Counter provides answers to many  common questions How big are the host cells? How uniform are  the host cells? Have any of the host cells broken apart? What is the relative percentage of debris to  desired cell type?
  • 12. Filtration Efficiency • After growing up cell culture, filtration is used to remove debris • Key parameters are efficiency and fouling‐ batch differences in  media culture can cause filter fouling • The Coulter Principle can be used to help select filters that  perform the best
  • 13. Data from Major Pharma Company Company was interested in removing the cellular debris/fragments prior to  pumping the supernatant into downstream processing steps.  First two curves  are as harvested (showing debris/fragment concentrations).  The remaining  curves are samples set aside in beakers etc that were then sampled. Two  different clarification filtering systems were used.
  • 14. Cell Banking:  Real Time  Measurement of Changes in Cell Size  • To permanently preserve cell lines, cryoprotectants are  used prior to freezing • Cryoprotectants themselves cause cell damage • Studying the rate of this damage and changes in cell size as  a function of time allows users to make better decisions  about preservation methods Mukherjee, et al, Cryobiology, 55(1):10-18. 2007
  • 15. Multi‐Tube Overlap:  Bacterial Aggregation in a Culture Bacterial aggregates can reduce the effectiveness of antimicrobial agents. A  combination of detergents and filters can be used to decrease the amount of  'clumps'.  The percentage of 'clumps' relative to single cells can be determined  by using two different apertures. The Multi‐Tube Overlap function merges the  results into a single continuous distribution.
  • 16. Corollary I: Which Bead  Formulations? • Micron Sized Beads are used in a variety of  cellular and biological applications Typically coated with recognition molecules Can be dye‐loaded, magnetic, or other… Optimization of formulation conditions is key • The Coulter Principle is the only technique that  can provide the resolution necessary for these  studies
  • 17. Corollary I: Which Bead  Formulations? Formulation A ~6 Formulation B ~12 ~18 ~24 The volume peaks increase by multiples of 6, indicating singlets, doublets, triplets, etc.
  • 18. Corollary II: Microbubble  Characterization • Large beads (2‐20 micron) Hollow and filled with imaging agents Most typically applied in ultrasound Heavy focus for biomedical research • The MultisizerTM allows researchers to  characterize these emerging imaging agents
  • 19. Particulates and Aggregates in Protein  Formulations Beckman Coulter Particle Characterization
  • 20. Protein Aggregates: Overview • Problem statement • The opportunity • How the Coulter Principle competes • Voice of the customer • Frequently asked questions • References • The Coulter Principle
  • 21. Problem Statement: • Protein scientists have identified an overlooked region of product quality data. Currently, techniques such as AUC, CE, and chromatography provide information up to 100 nm particles in size. Other technologies, such as light blockage provide information above 10 micron in size. • A “blind spot” exists with particles between 100 nm and 10 micron. Particles in this range may cause immunogenicity. Active studies of this size range began in mid-2008. Regulators are demanding data in this range. Journal of Pharmaceutical Science-2009
  • 22. Genzyme Case Study: Importance of Particles in Biologics Genzyme says FDA will oversee its factory By ANDREW POLLACK NEW YORK TIMES, Published: March 24, 2010 November 2009 FDA reports that Cerezyme, Fabrazyme and three other enzyme drugs that are put into vials at the factory were contaminated with PARTICLES of steel, rubber or fiber. Financial analyst predicts the overall cost to the Genzyme will be in the $200 million to $300 million range Key Message FOREIGN OR PROTEINACEUOS PARTICLES HAVE THE POTENTIAL TO MAKE PEOPLE SICK
  • 23. The Opportunity: Regulatory pressure is forcing manufacturers to  account for particulates of smaller and smaller  sizes.   Current lower limit =10 micron Likely future lower limit = 1 micron Currently used technologies do not perform well  below 10 micron The Multisizer™4 has been shown to be very  effective in this size range.
  • 24. The Opportunity: • FDA & EMEA require data for particulates less  than 10 micron, but do not specify the technique  that should be used. USP and EDQM pharmacopeias DO establish  acceptable techniques for FOREIGN particles greater  than 10 µm Two current, acceptable techniques for foreign  particulates greater than 10 µm ‐ Technique 1: Light Obscuration ‐ Technique 2: Microscopy USP: United States Pharmacopeia EMEA: European Medicines Agency
  • 25. The Opportunity: • Competing techniques being evaluated for  particulates less than 10 micron: The Coulter Principle (BEC) Light Blockage (HIAC) Flow Imaging (MFI, Flowcam)
  • 26. Opportunity Matrix: Particulate Less than Greater than Characteristics 10 micron 10 micron Foreign Covered by current Opportunity for MS4 Particulates USP & EMEA Methods Protein Opportunity for MS4 Opportunity for MS4 Aggregates USP: United States Pharmacopeia EMEA: European Medicines Agency
  • 27. Coulter Principle: Advantage MultisizerTM 4 Data from Actual Protein Therapeutic 1.20E+05 Pre-filtration Approx. flow Post-Filtration Number per mL imaging lower limit (~1.5 μm) 6.00E+04 Approx. light blockage lower limit (~2 μm) 0.00E+00 0.4 1.9 3.4 Diameter (mm) Diameter (μm) Other techniques miss the majority of particulates
  • 28. Technique Comparison: Handles Min Operating Min Max Transparent Sample Principle Particles? Size Concentration Volume Light 2.0 18,000 Light Based Questionable 2 mL Blockage micron particles/mL Flow 1.5 750,000 Light Based Questionable 2 mL Imaging micron particles/mL Coulter 0.4 >1,000,000 Principle Impedance Excellent 4 mL micron particles/mL MultisizerTM
  • 29. How can we estimate aggregate mass? Mass = Density x Volume
  • 31. Voice of the Customer: “We WANT…” 1. Accurate counts below 10 micron, and  ideally as low as 0.1 micron 2. The ability to run samples neat 3. Total sampling volumes between 2 and 5 mL 4. Extremely linear and reproducible data
  • 32. How We Meet Customer Needs: Accurate counts below 10μm, ideally as low as 0.1μm  The MS4 is the only instrument that can count particulates  under 1 μm and down to 0.400 μm.  The ability to run samples neat  The MS4 can count proteins in a wide variety of native buffers  without dilution  Sampling volumes between 2 and 5 mL  Our new sample procedure and adaptor allow s volumes as  small as 4 mL  Extremely linear and reproducible data  The MS4 is highly sensitive and reproducible  Typical CV's are below 2%  The Coulter Principle has been used as the #1 method for  counting red blood cells for over 50 years 
  • 33. Frequently Asked Questions “Do you have to dilute?” Not necessarily.  Depends on sample characteristics and  smallest size range needed.   Protein scientists often dilute for other analyses (size  exclusion chromatography, CE, AUC) “Can you provide morphology information?” Ask why this is important.  Customers are most  concerned about counts and current flow image  techniques and rely upon image aspect ratios for  morphology
  • 34. Frequently Asked Questions “Can you count down to 100 nm?” How low can you count now? The MultisizerTM is the  only instrument with accurate and reproducible data  below 1 micron. “What sample volumes are required?” The standard set up accommodates 10 mL.  However,  we have a special technique for proteins that can use  as little as 4 mL. “What is the Coulter Principle?” It uses electrical impedance to count and size  particles.  It has been around for more than 55 years  and widely used as a counting standard.